Clinical Trials Logo

Clinical Trial Summary

In recent years, the lysine analogs tranexamic acid (TXA) has gained wide use in cardiac surgery as a blood-sparing agent. However, the safety of the drug and its impact on overall outcomes of cardiac surgery remains debated. The current study evaluates the dose effect of TXA on the incidence of deep venous thrombus (DVT) in cardiac surgery with cardiopulmonary bypass. Also, the dose effect of TXA on bleeding and allogeneic transfusion is evaluated.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03838328
Study type Interventional
Source Chinese Academy of Medical Sciences, Fuwai Hospital
Contact Jia Shi, M.D.
Phone 86 10 88322467
Email shiandypumc@sina.com
Status Not yet recruiting
Phase Phase 4
Start date March 1, 2019
Completion date March 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03359525 - Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty Phase 4
Completed NCT03823573 - Implementation of a Rapid Recovery Protocol in Total Knee Arthroplasty N/A
Completed NCT05696951 - Tranexamic Acid in Sleeve Gastrectomy N/A
Not yet recruiting NCT04192643 - INTERVENTION WITH TRANEXAMIC ACID TO REDUCE HAEMORRHAGE DURING LAPAROSCOPIC MYOMECTOMY N/A
Completed NCT03019198 - TRANEXAMIC ACID IN PATIENTS UNDERGOING TOTAL HIP ARTHROPLASTY IN A BRAZILIAN REFERENCE ORTHOPEDIC CENTER: A RANDOMIZED CONTROLLED TRIAL Phase 4